Venous thromboembolism after total joint arthroplasty: Results from a Japanese multicenter cohort study

Arthritis Research and Therapy

Volumn 16, Issue 4, 2014, Pages

  Migita, Kiyoshi ^a   Bito, Seiji ^b   Nakamura, Mashio ^c   Miyata, Shigeki ^d   Saito, Masanobu ^a   Kakizaki, Hirosi ^a   Nakayama, Yuichiro ^a   Matsusita, Tomohiro ^a   Furuichi, Itaru ^a   Sasazaki, Yoshihiro ^a   Tanaka, Takaaki ^a   Yoshida, Mamoru ^a   Kaneko, Hironori ^a   Abe, Isao ^a   Mine, Takatomo ^a   Ihara, Kazuhiko ^a   Kuratsu, Shigeyuki ^a   Saisho, Koichiro ^a   Miyahara, Hisaaki ^a   Segata, Tateki ^a   Nakagawa, Yasuaki ^a   Kamei, Masataka ^d   Torigoshi, Takafumi ^a   Motokawa, Satoru ^a,e   more..

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CILOSTAZOL; ENOXAPARIN; FONDAPARINUX; HEPARIN; ANTICOAGULANT AGENT; POLYSACCHARIDE;

ADULT; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; ECHOGRAPHY; EMBOLISM PREVENTION; FEMALE; GENDER; HUMAN; INCIDENCE; JAPANESE (PEOPLE); LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROPENSITY SCORE; PUMP; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL PATIENT; SURGICAL RISK; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; VERY ELDERLY; ADVERSE EFFECTS; ARTHROPLASTY; CLINICAL TRIAL; JAPAN; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; COHORT STUDIES; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84904446379     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4616     Document Type: Article

References (45)

1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:338S-400S. 10.1378/chest.126.3_suppl.338S, 15383478.
2. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998, 158:1525-1531. 10.1001/archinte.158.14.1525, 9679793.
3. Colwell CW. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty. Orthopedics 2009, 32:67-73. 10.3928/01477447-20091103-51, 20201479.
4. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW,. American College of Chest Physicians Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e278S-e325S. 10.1378/chest.11-1986, 3278063, 22315265, American College of Chest Physicians.
5. MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, McLeod S, Bhatnagar N, Guyatt GH,. American College of Chest Physicians Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e1S-e23S. 3278050, 22315262, American College of Chest Physicians.
6. Eerenberg ES, van Es J, Sijpkens MK, Büller HR, Kamphuisen PW. New anticoagulants: moving on from scientific results to clinical implementation. Ann Med 2011, 43:606-616. 10.3109/07853890.2011.606829, 21864021.
7. Baser O, Supina D, Sengupta N, Wang L. Anticoagulation Bridging Therapy Patterns in Patients Undergoing Total Hip or Total Knee Replacement in a US Health Plan: Real-World Observations and Implications. Am Health Drug Benefits 2011, 4:240-248.
8. Selby R, Borah BJ, McDonald HP, Henk HJ, Crowther M, Wells PS. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement. Thromb Res 2012, 130:166-172. 10.1016/j.thromres.2012.01.013, 22365491.
9. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?. Chest 2009, 135:513-520. 10.1378/chest.08-2655, 19201714.
10. Lachiewicz PF. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics 2009, 32:74-78. 10.3928/01477447-20091103-52, 20201480.
11. Fuji T, Fujita S, Ochi T. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop 2008, 32:443-451. 10.1007/s00264-007-0360-7, 2532275, 17468868.
12. Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci 2008, 13:442-451. 10.1007/s00776-008-1264-0, 18843459.
13. Kory PD, Pellecchia CM, Shiloh AL, Mayo PH, DiBello C, Koenig S. Accuracy of ultrasonography performed by critical care physicians for the diagnosis of DVT. Chest 2011, 139:538-542. 10.1378/chest.10-1479, 21030490.
14. Schwarz T, Schmidt B, Schellong SM. Interobserver agreement of complete compression ultrasound for clinically suspected deep vein thrombosis. Clin Appl Thromb Hemost 2002, 8:45-49. 10.1177/107602960200800106, 11991239.
15. Schellong SM. Complete compression ultrasound for the diagnosis of venous thromboembolism. Curr Opin Pulm Med 2004, 10:350-355. 10.1097/01.mcp.0000136402.24828.0e, 15316431.
16. Schellong SM, Beyer J, Kakkar AK, Halbritter K, Eriksson BI, Turpie AG, Misselwitz F, Kälebo P. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost 2007, 5:1431-1437. 10.1111/j.1538-7836.2007.02570.x, 17419763.
17. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol 2006, 163:1149-1156. 10.1093/aje/kwj149, 1513192, 16624967.
18. Anderson FA, Hirsh J, White K, Fitzgerald RH,. Hip and Knee Registry Investigators Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 2003, 124:349S-356S. 10.1378/chest.124.6_suppl.349S, 14668417, Hip and Knee Registry Investigators.
19. Maletis GB, Inacio MC, Reynolds S, Funahashi TT. Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. J Bone Joint Surg Am 2012, 94:714-720.
20. Fuji T, Fujita S, Tachibana S, Kawai Y. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty. J Thromb Haemost 2010, 8:2458-2468. 10.1111/j.1538-7836.2010.04021.x, 20723033.
21. Nagase Y, Yasunaga H, Horiguchi H, Hashimoto H, Shoda N, Kadono Y, Matsuda S, Nakamura K, Tanaka S. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Joint Surg Am 2011, 93:e146.
22. Xing KH, Morrison G, Lim W, Douketis J, Odueyungbo A, Crowther M. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Thromb Res 2008, 123:24-34. 10.1016/j.thromres.2008.05.005, 18620740.
23. White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med 2002, 8:365-371. 10.1097/00063198-200209000-00004, 12172437.
24. Friedman RJ, Gallus A, Gil-Garay E, FitzGerald G, Cushner F. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty-insights from the Multinational Global Orthopaedic Registry (GLORY). Am J Orthop 2010, 39:14-21.
25. Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B,. IMECCHI Group Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 2012, 307:294-303. IMECCHI Group.
26. Angchaisuksiri P. Venous thromboembolism in Asia-an unrecognised and under-treated problem?. Thromb Haemost 2011, 106:585-590. 10.1160/TH11-03-0184, 21833449.
27. Pitto RP, Hamer H, Heiss-Dunlop W, Kuehle J. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg (Br) 2004, 86:639-642. 10.1302/0301-620X.86B5.14763, 15274256.
28. Wilson NV, Das SK, Kakkar VV, Maurice HD, Smibert JG, Thomas EM, Nixon JE. Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V Impulse System. J Bone Joint Surg B 1992, 74:50-52.
29. Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998, 80:1158-1166.
30. Parker MJ, Handoll HH, Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2004, 18:CD000521.
31. Sharrock NE, Haas SB, Hargett MJ, Urquhart B, Insall JN, Scuderi G. Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am 1991, 73:502-506.
32. Williams-Russo P, Sharrock NE, Haas SB, Insall J, Windsor RE, Laskin RS, Ranawat CS, Go G, Ganz SB. Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement. Clin Orthop Relat Res 1996, 331:199-208.
33. Eriksson BI, Bauer KA, Lassen MR, Turpie AG,. Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001, 345:1298-1304. 10.1056/NEJMoa011100, 11794148, Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study.
34. Lassen MR, Bauer KA, Eriksson BI, Turpie AG,. European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002, 359:1715-1720. 10.1016/S0140-6736(02)08652-X, 12049858, European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee.
35. Turpie AG, Bauer KA, Eriksson BI, Lassen MR,. PENTATHALON 2000 Study Steering Committee Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002, 359:1721-1726. 10.1016/S0140-6736(02)08648-8, 12049860, PENTATHALON 2000 Study Steering Committee.
36. Bauer KA, Eriksson BI, Lassen MR, Turpie AG,. Steering Committee of the Pentasaccharide in Major Knee Surgery Study Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001, 345:1305-1310. 10.1056/NEJMoa011099, 11794149, Steering Committee of the Pentasaccharide in Major Knee Surgery Study.
37. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002, 162:1833-1840. 10.1001/archinte.162.16.1833, 12196081.
38. Colwell CW, Kwong LM, Turpie AG, Davidson BL. Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery. J Arthroplasty 2006, 21:36-45. 10.1016/j.arth.2005.05.023, 16446183.
39. Nagler M, Haslauer M, Wuillemin WA. Fondaparinux - data on efficacy and safety in special situations. Thromb Res 2012, 129:407-417. 10.1016/j.thromres.2011.10.037, 22133273.
40. Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, Kahn SR, Falck-Ytter Y, Francis CW, Lansberg MG, Akl EA, Hirsh J,. American College of Chest Physicians Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e185S-e194S. 3278047, 22315260, American College of Chest Physicians.
41. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e351S-e418S. 3278048, 22315267.
42. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg (Br) 2007, 89:799-807.
43. Lopes RD, Subherwal S, Holmes DN, Thomas L, Wang TY, Rao SV, Magnus Ohman E, Roe MT, Peterson ED, Alexander KP. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 2012, 33:2044-2053. 10.1093/eurheartj/ehs012, 3418508, 22396323.
44. Kassaï B, Boissel JP, Cucherat M, Sonie S, Shah NR, Leizorovicz A. A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. Thromb Haemost 2004, 91:655-666. 2706694, 15045125.
45. Bressollette L, Nonent M, Oger E, Garcia JF, Larroche P. Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients-the TADEUS project. Thromb Haemost 2001, 86:529-533.